Docetaxel, cisplatin, and fluorouracil in gastric cancer: Does the punishment fit the crime? Journal Article


Author: Ilson, D. H.
Article Title: Docetaxel, cisplatin, and fluorouracil in gastric cancer: Does the punishment fit the crime?
Keywords: cancer chemotherapy; cancer survival; treatment outcome; clinical trial; neutropenia; cisplatin; doxorubicin; fluorouracil; diarrhea; drug dose reduction; drug efficacy; drug withdrawal; unspecified side effect; capecitabine; methotrexate; drug megadose; low drug dose; quality of life; etoposide; blood toxicity; nausea; stomatitis; antineoplastic combined chemotherapy protocols; editorial; combination chemotherapy; continuous infusion; docetaxel; irinotecan; febrile neutropenia; fever; drug fatality; folinic acid; neoplasm metastasis; nausea and vomiting; stomach cancer; epirubicin; platinum derivative; taxoids; taxane derivative; anthracycline derivative; dna topoisomerase inhibitor; mitomycin; oxaliplatin; esophagus cancer; alopecia; stomach neoplasms; fluoropyrimidine derivative; esophageal neoplasms; mucosal disease; clinical trials, phase iii
Journal Title: Journal of Clinical Oncology
Volume: 25
Issue: 22
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2007-08-01
Start Page: 3188
End Page: 3190
Language: English
DOI: 10.1200/jco.2006.10.2210
PUBMED: 17664464
PROVIDER: scopus
DOI/URL:
Notes: --- - "Cited By (since 1996): 24" - "Export Date: 17 November 2011" - "CODEN: JCOND" - "Source: Scopus"
Altmetric
Citation Impact
MSK Authors
  1. David H Ilson
    414 Ilson